Vol 2017, No 2 (2017)

Table of Contents

Mergers & Acquisitions

Eli Lilly acquires CoLucid to Expand Pain Portfolio Abstract pdf html
Natasha Piper
J&J Boosts Orphan Drug Portfolio with US$30 B Takeover of Actelion’s Marketed and Late-Stage Assets Abstract pdf
Jasmine Kalsi, Vipul Sikka & Heather Cartwright
Ipsen Boosts Oncology Pipeline with Merrimack’s Assets Abstract pdf html
Jasmine Kalsi & Arun Manohar


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.